Trending Stock News

Montag & Caldwell Lowered Intercontinental Exchange (ICE) Holding by $10.93 Million as Stock Value Rose; Villere St Denis J & Co Decreased Its Position in Abbott Labs (ABT) by $601,065

Abbott Laboratories (NYSE:ABT) Logo

Montag & Caldwell Llc decreased its stake in Intercontinental Exchange Inc (ICE) by 9.67% based on its latest 2017Q4 regulatory filing with the SEC. Montag & Caldwell Llc sold 156,129 shares as the company’s stock rose 2.21% while stock markets declined. The institutional investor held 1.46M shares of the investment bankers and brokers and service company at the end of 2017Q4, valued at $102.96M, down from 1.62 million at the end of the previous reported quarter. Montag & Caldwell Llc who had been investing in Intercontinental Exchange Inc for a number of months, seems to be less bullish one the $41.44 billion market cap company. The stock decreased 1.17% or $0.85 during the last trading session, reaching $71.55. About 1.66M shares traded. Intercontinental Exchange, Inc. (NYSE:ICE) has risen 20.88% since May 20, 2017 and is uptrending. It has outperformed by 9.33% the S&P500.

Villere St Denis J & Co Llc decreased its stake in Abbott Labs (ABT) by 4.02% based on its latest 2017Q4 regulatory filing with the SEC. Villere St Denis J & Co Llc sold 10,545 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 251,465 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $14.35 million, down from 262,010 at the end of the previous reported quarter. Villere St Denis J & Co Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $108.19B market cap company. The stock increased 1.06% or $0.65 during the last trading session, reaching $61.71. About 6.36M shares traded or 0.69% up from the average. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 20, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since December 14, 2017, it had 1 buy, and 20 sales for $23.69 million activity. PEDERSON MICHAEL J also sold $27,213 worth of Abbott Laboratories (NYSE:ABT) shares. Shares for $375,381 were sold by Contreras Jaime. 28,319 Abbott Laboratories (NYSE:ABT) shares with value of $1.56M were sold by Salvadori Daniel Gesua Sive. On Friday, February 16 the insider Fussell Stephen R sold $3.36M. Watkin Jared also sold $58,635 worth of Abbott Laboratories (NYSE:ABT) on Wednesday, February 28. 42,665 shares valued at $2.69M were sold by Ford Robert B on Tuesday, January 30.

Villere St Denis J & Co Llc, which manages about $3.49B and $1.61 billion US Long portfolio, upped its stake in Chevron Corp New (NYSE:CVX) by 18,285 shares to 74,898 shares, valued at $9.38 million in 2017Q4, according to the filing. It also increased its holding in Verizon Communications Inc (NYSE:VZ) by 12,105 shares in the quarter, for a total of 177,555 shares, and has risen its stake in Ebix Inc (NASDAQ:EBIX).

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.73 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Moreover, Next Fincl Grp has 0.17% invested in Abbott Laboratories (NYSE:ABT) for 6,980 shares. Beech Hill Advsrs accumulated 0.37% or 13,189 shares. Griffin Asset Mgmt Incorporated holds 131,140 shares. Prudential Public Ltd Co has 1.80 million shares for 0.31% of their portfolio. Citadel Advsr Lc invested in 0.23% or 6.49 million shares. Spinnaker accumulated 30,726 shares. Bluefin Trading stated it has 0.39% of its portfolio in Abbott Laboratories (NYSE:ABT). Ronna Sue Cohen has 83,854 shares for 3.41% of their portfolio. The Florida-based Ifc Fl has invested 0.08% in Abbott Laboratories (NYSE:ABT). Lingohr & Partner Asset Gmbh holds 0.22% of its portfolio in Abbott Laboratories (NYSE:ABT) for 7,400 shares. Beck Mack And Oliver Limited Com, New York-based fund reported 1.40 million shares. Chesley Taft Assocs Ltd Liability Com reported 330,968 shares or 1.6% of all its holdings. Robeco Institutional Asset Bv accumulated 131,413 shares. Patten Group Incorporated, a Tennessee-based fund reported 1,424 shares. British Columbia Inv Mngmt has 763,979 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. Cowen & Co maintained the stock with “Buy” rating in Friday, September 22 report. Morgan Stanley maintained Abbott Laboratories (NYSE:ABT) rating on Tuesday, July 11. Morgan Stanley has “Equal-Weight” rating and $4 target. On Tuesday, January 2 the stock rating was upgraded by Morgan Stanley to “Overweight”. The stock has “Overweight” rating by Barclays Capital on Wednesday, October 7. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, January 24. The stock has “Neutral” rating by UBS on Tuesday, September 22. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, July 23. The stock has “Neutral” rating by Citigroup on Thursday, October 19. On Friday, July 21 the stock rating was maintained by Deutsche Bank with “Buy”. The firm has “Hold” rating given on Monday, October 2 by BMO Capital Markets.

Montag & Caldwell Llc, which manages about $14.22 billion and $3.18 billion US Long portfolio, upped its stake in Apple Inc (NASDAQ:AAPL) by 173,959 shares to 824,786 shares, valued at $139.58M in 2017Q4, according to the filing. It also increased its holding in Fleetcor Technologies Inc (NYSE:FLT) by 162,464 shares in the quarter, for a total of 423,629 shares, and has risen its stake in Analog Devices Inc (NASDAQ:ADI).

Among 20 analysts covering Intercontinental Exchange (NYSE:ICE), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Intercontinental Exchange had 69 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by UBS on Friday, November 3. The firm earned “Hold” rating on Sunday, August 9 by Standpoint Research. Wood maintained Intercontinental Exchange, Inc. (NYSE:ICE) rating on Friday, April 8. Wood has “Outperform” rating and $286 target. The rating was maintained by UBS on Thursday, August 4 with “Buy”. The firm earned “Buy” rating on Thursday, April 13 by Wood. The stock has “Buy” rating by Jefferies on Tuesday, April 11. On Wednesday, October 11 the stock rating was maintained by Jefferies with “Buy”. J.P. Morgan upgraded the stock to “Buy” rating in Tuesday, February 20 report. On Thursday, October 19 the stock rating was maintained by Citigroup with “Neutral”. Barclays Capital maintained the shares of ICE in report on Tuesday, August 11 with “Overweight” rating.

Analysts await Intercontinental Exchange, Inc. (NYSE:ICE) to report earnings on August, 2. They expect $0.87 earnings per share, up 16.00% or $0.12 from last year’s $0.75 per share. ICE’s profit will be $503.93 million for 20.56 P/E if the $0.87 EPS becomes a reality. After $0.90 actual earnings per share reported by Intercontinental Exchange, Inc. for the previous quarter, Wall Street now forecasts -3.33% negative EPS growth.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *